Mikael Roland Karlsson

ACR Capital Holdings Pte Ltd. engages in the provision of risk solutions and reinsurance services. It offers solutions in the business lines of agriculture; aviation; credit and surety; energy; and marine. The company was founded by Kwang Kherng Tan in 2006 and is headquartered in Singapore.

Innovationsbron Rendera Saddkapital AB, also known as Innovationsbron Render Seed Capital AB, is a wholly-owned subsidiary of Innovationsbron AB, a funding and development agency of the Swedish Government. Established in 2004, Rendera is located in Linköping in southwestern Sweden. The firm specializes in seed capital investments and receives public funding from regional entities. Being government-funded, they tend to operate in the precompetitive arena.

Efield AB designs and develops electromagnetic analysis simulation software. It is a software development company that primarily offers integrated electromagnetic simulation system. It offers FD hybrid add-on, TD hybrid add-on, and parallel add-on. The firm also provides pre-processing, time domain solvers, frequency domain solvers, waveguide modelover, post-processing, high performance computing, and cavity RCS tool. The company was founded in 2006 and is headquartered in Sollentuna, Sweden.

RGB Technologies AB is a development company that has developed a software and hardware platform based on readily available instrumentation: computers and web cameras or cellphones for point of care applications, general health controls and distributed environmental monitoring. The company has potential end users for medical diagnostics among hospitals, primary care, gyms and users at home. The platform enables also distributed water and air quality measurements where potential end users are environmental inspectors and users in individual homes. The company was founded in 2004 and is located in Stockholm, Sweden.

Selectica Pharmaceuticals business proposition is to develop anti-inflammatory drugs from pre-clinical to Phase II a clinical trials. Pre-clinical and clinical development of candidate drugs will take place through independent financing and collaborations with established pharmaceutical companies. Selectica Pharmaceuticals was founded 1999 on a solid base of experience and research within the biomedical area. The company has discovered and documented specific inhibitors of acute and chronic inflammation. In the pathophysiology of several chronic inflammatory diseases, leukocyte extravasations plays an important, if not crucial, role. A novel approach for therapeutic modulation of inflammation is inhibition of cell adhesion.

Almi Invest AB (Almi) is a Venture Capital subsidiary of ALMI Företagspartner AB, founded in 2009. The firm is headquartered in Stockholm, Sweden.

Part of Actis LLP, Aquila Renewable Ltd. is a holding British company that operates wind and solar power projects through its subsidiaries. The company is based in London, UK and was founded in 2013.